U. Gatzemeier
Ontario Institute for Cancer Research(CA)Eli Lilly (United States)(US)Heidelberg University(DE)Royal Prince Alfred Hospital(AU)Texas Oncology(US)Institut Gustave Roussy(FR)University Hospital Heidelberg(DE)Allgemeines Krankenhaus Celle(DE)Frauenklinik Heidelberg(DE)Indiana University – Purdue University Indianapolis(US)Hacettepe University(TR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer therapeutics and mechanisms, Lung Cancer Diagnosis and Treatment, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer(2008)3,206 cited
- → Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma(2003)3,045 cited
- → Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy(2004)2,425 cited
- → Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1(2004)1,720 cited
- → Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial(2009)1,354 cited
- → Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial